Femara letrozole: Phase III; marketed to treat locally advanced or metastatic breast cancer

Updated results from a previously reported Phase III trial comparing Femara to tamoxifen in 907 post-menopausal women with locally advanced or metastatic

Read the full 222 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE